תוצאות חיפוש - Arkendu Chatterjee

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Pembrolizumab in relapsed or refractory Richter syndrome

    Pembrolizumab in relapsed or refractory Richter syndrome מאת Philippe Armand, Niels Murawski, Daniel Molin, Jasmine Zain, Barbara Eichhorst, Zafer Gülbaş, Eliza A. Hawkes, John M. Pagel, Tycel Phillips, Vincent Ribrag, Jakub Svoboda, Anastasios Stathis, Arkendu Chatterjee, Robert Orlowski, Patricia Marinello, Beth Christian

    יצא לאור 2020
    קבל טקסט מלא
    Carta
    הוספה למועדפים
    שמור ב:
  2. 2
    Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial

    Efficacy and safety of pembrolizumab in relapsed/refractory primary mediastinal large B‐cell lymphoma (rrPMBCL): interim analysis of the KEYNOTE‐170 phase 2 trial מאת Pier Luigi Zinzani, Catherine Thiéblemont, В Я Мельниченко, Dzhelil Osmanov, Krimo Bouabdallah, Jan Walewski, Alejandro Majlis, Laura Fogliatto, M. D. Caballero Barrigón, Christian Bach, Zafer Gülbaş, Muhi̇t Özcan, Gilles Salles, Margaret A. Shipp, Arun Balakumaran, Sabine Chlosta, Arkendu Chatterjee, Philippe Armand

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study

    Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study מאת Rohit Loomba, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Stephen A. Harrison, Eric Lawitz, Nadege Gunn, Kento Imajo, Natarajan Ravendhran, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Manal F. Abdelmalek

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

    Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study מאת Manal F. Abdelmalek, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander‐Tetri, Zachary Goodman, Eric Lawitz, Stephen A. Harrison, Ira M. Jacobson, Kento Imajo, Nadege Gunn, Dina Halegoua‐DeMarzio, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Rohit Loomba

    יצא לאור 2023
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

    Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study מאת Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoîne Italiano, Tormod Kyrre Guren, Marloes G. J. van Dongen, Kristen Spencer, Giovanni M. Bariani, Paolo A. Ascierto, Armando Santoro, Manisha H. Shah, Jamil Asselah, Syma Iqbal, Shunji Takahashi, Sarina A. Piha‐Paul, Patrick A. Ott, Arkendu Chatterjee, Fan Jin, Kevin Norwood, Jean‐Pierre Delord

    יצא לאור 2022
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic<i>BRAF</i>-Mutant Colorectal Cancer

    A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic<i>BRAF</i>-Mutant Colorectal Cancer מאת Robin M.J.M. van Geel, Josep Tabernero, Elena Élez, Johanna C. Bendell, Anna Spreafico, Martin Schüler, Takayuki Yoshino, Jean‐Pierre Delord, Yasuhide Yamada, Martijn P. Lolkema, Jason E. Faris, Ferry A.L.M. Eskens, Sunil Sharma, Rona Yaeger, Heinz‐Josef Lenz, Zev A. Wainberg, Emin Avşar, Arkendu Chatterjee, Savina Jaeger, Eugene Tan, Kati Maharry, Tim Demuth, Jan H.M. Schellens

    יצא לאור 2017
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

    Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies מאת Philippe Armand, Scott J. Rodig, В Я Мельниченко, Catherine Thiéblemont, Krimo Bouabdallah, Gayane Tumyan, Muhi̇t Özcan, Sergio Portiño, Laura Fogliatto, Dolores Caballero, Jan Walewski, Zafer Gülbaş, Vincent Ribrag, Beth Christian, Guilherme Fleury Perini, Gilles Salles, Jakub Svoboda, Jasmine Zain, Sanjay S. Patel, Pei-Hsuan Chen, Azra H. Ligon, Jing Ouyang, Donna Neuberg, Robert Redd, Arkendu Chatterjee, Robert Orlowski, Arun Balakumaran, Margaret A. Shipp, Pier Luigi Zinzani

    יצא לאור 2018
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

    Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma מאת Philippe Armand, Scott J. Rodig, В Я Мельниченко, Catherine Thiéblemont, Kamal Bouabdallah, Gayane Tumyan, Muhıt Özcan, Sergio Portiño, Laura Fogliatto, Marı́a Dolores Caballero, Jan Walewski, Zafer Gülbaş, Vincent Ribrag, Beth Christian, Guilherme Fleury Perini, Gilles Salles, Jakub Svoboda, Jasmine Zain, Sanjay S. Patel, Pei-Hsuan Chen, Azra H. Ligon, Jing Ouyang, Donna Neuberg, Robert Redd, Arkendu Chatterjee, Arun Balakumaran, Robert Orlowski, Margaret A. Shipp, Pier Luigi Zinzani

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: